The Peripheral Artery Disease market industry is projected to grow from USD 2.69 Billion in 2023 to USD 4.91 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast period (2023 - 2032).
The
Peripheral Artery Disease (PAD) market is witnessing steady growth globally,
driven by an aging population, lifestyle changes, and increasing incidences of
diabetes and obesity. With rising awareness about PAD's prevalence and its
associated risks, demand for innovative treatments and diagnostic technologies
is escalating. Key players are focusing on developing advanced therapies,
including drug-eluting stents, angioplasty balloons, and atherectomy devices,
to address critical unmet needs. Additionally, emphasis on early diagnosis
through non-invasive imaging techniques is shaping the market landscape.
Despite regulatory hurdles and reimbursement challenges, collaborations,
mergers, and acquisitions remain prominent strategies among industry
stakeholders to expand market presence and enhance patient outcomes.
The
Peripheral Artery Disease (PAD) market is witnessing significant growth as
awareness about arterial peripheral vascular disease increases globally. PAD,
also known as peripheral arteriopathy, is a condition characterized by the
narrowing or blockage of arteries, primarily in the legs, due to the buildup of
fatty deposits. This restricts blood flow to the limbs, leading to symptoms
like leg pain, cramping, and numbness, which can severely impact mobility and
quality of life.
In
recent years, advancements in medical technology and increased investment in
research have fueled the development of innovative treatments and therapies for
PAD. Pharmaceutical companies and medical device manufacturers are focusing on
introducing novel drugs, minimally invasive procedures, and cutting-edge
diagnostic tools to effectively manage PAD and improve patient outcomes.
The
rising prevalence of risk factors such as diabetes, obesity, and smoking
further underscores the need for improved PAD management strategies. Healthcare
providers are emphasizing the importance of early detection and comprehensive
care to prevent complications and reduce the burden of PAD-related
disabilities.
With
a growing aging population and increasing awareness about cardiovascular
health, the demand for PAD treatments is expected to surge in the coming years.
Market players are striving to address unmet medical needs and expand their
product portfolios to cater to the evolving requirements of patients and
healthcare professionals alike. As research continues to unravel new insights
into the pathophysiology of peripheral arterial diseases, the PAD market is
poised for remarkable growth and innovation.
Global
Peripheral Artery Disease Market: Segmental Analysis
The
segment analysis of the market has been conducted based on devices, drugs, and
types of diseases.
On
the basis of devices, the market has been segmented into atherectomy devices,
angioplasty balloon catheters, stents and others. The stents segment is further
sub-segmented into self-expandable and balloon expandable. The atherectomy
devices segment is further sub-segmented into orbital, directional, rotational
and laser.
On
the basis drugs, the market has been segmented into glucose regulating drug,
lipid-lowering drugs and other. Based of types of diseases, the market has been
segmented into lymphedema, blood clotting disorders, atherosclerosis and other.
Global
Peripheral Artery Disease Market: Competition Analysis
The
Peripheral Artery Disease companies are B. Braun Melsungen AG, Boston
Scientific Corporation, TERUMO CORPORATION, Sanofi S.A., AstraZeneca Plc.,
Bristol-Myers Squibb Company, Merck & Co., Inc., Symic Bio, Inc.,
CardioVascular BioTherapeutics, Inc., Medtronic., KONINKLIJKE PHILIPS N.V,
Proteon Therapeutics, Inc., Smith & Nephew plc, Bayer HealthCare
Pharmaceuticals, Zimmer Biomet Holdings, Inc., Abbott, Dickinson and Company
(BD), Cook Medical, Becton, Johnson & Johnson Services, Inc., Alcon
Laboratories, Inc., Angioscore, Inc., Betagenon AB, TheraVasc Inc., Aspen
Surgical Products, Inc., Stryker Corporation,
AnGes, Inc. and Cordis are among the top-notch companies operating in
the market.
Global
Peripheral Artery Disease Market: Regional Analysis
Regions
covered in the report include Europe, the Middle East & Africa (MEA), Asia
Pacific (APAC), and North America. A vast and robust healthcare sector in the
U.S. makes North America a major market for peripheral artery disease
treatment. Extensive healthcare penetration coupled with sound medical
expertise and high medical healthcare expenditure. Additionally, rising patient
pool is a key driver of the market in North America. Development of peripheral
artery diseases is also linked with obesity and diabetes. The APAC peripheral
artery disease market is also anticipated to witness a healthy growth over the
next several years. Increased focus on improving the care quality propelling
the market growth in the region. During the forecast period, the market in the
region is expected to exhibit the highest growth.
Related Reports:
Type 2 Diabetes Mellitus
Treatment
Healthcare Supply Chain
Management
For More Information, Please Visit @ Market Research Future
0 Comments